Tag: Diabetes treatment

Browse exclusive Tags!

Enzyme Discovery Offers New Hope for Diabetes Treatment, US

New hope for diabetes treatment with the discovery of an enzyme that blocks insulin production. Promising potential for targeted therapies. Breaking research by Case Western Reserve University and University Hospitals.

Researchers Discover Breakthrough in Diabetes Understanding, Paving the Way for New Treatments

Researchers discover breakthrough in diabetes understanding, paving the way for new treatments. Study identifies enzyme linked to insulin function and potential target for medication development. Exciting progress in diabetes research.

Discovery of NEUROG3 Gene’s Role in Pancreas Development Could Revolutionize Diabetes Treatment, Germany

Discover how the NEUROG3 gene revolutionizes diabetes treatment by unlocking the potential to produce more hormone-producing cells for transplantation - a game-changer for diabetes patients.

Novo Nordisk’s Semaglutide Shows Promising Results in Landmark Trial, Could Expand Use Beyond Diabetes Treatment, India

Promising results for semaglutide in landmark trial, potentially expanding its use beyond diabetes treatment. Findings could benefit obesity and cardiovascular disease patients.

Popular

Major Acquisition: Biopharmaceutical Giant Acquires Two Companies for Obesity & Diabetes Treatments

Biopharmaceutical giant completes major acquisition, revolutionizing obesity and diabetes treatments. Learn more about their innovative solutions.

SDRI’s Remarkable Breakthroughs in 2022: Paving the Way for Progress

Discover the groundbreaking advancements in diabetes research, education, and care highlighted in SDRI's 2022 annual report. Transforming lives through innovative therapies.

NPPA Expands Price Control to 23 More Drugs

India's National Pharmaceutical Pricing Authority has extended price control regulations to include 23 more drugs for illnesses such as arthritis, tuberculosis and diabetes. Manufacturers must now review their pricing to ensure patients are not being overcharged. This move aims to make drugs more affordable for patients, with ceiling prices set for essential treatments. Manufacturers must also provide regulators with a full list of prices via the IPDMS, and display a price list at their business site for easy access.

Novo Nordisk’s Semaglutide Shows Promising Results in Landmark Trial, Could Expand Use Beyond Diabetes Treatment, India

Promising results for semaglutide in landmark trial, potentially expanding its use beyond diabetes treatment. Findings could benefit obesity and cardiovascular disease patients.

Subscribe

spot_imgspot_img